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Short-term  assist  devices  have  been  indicated  in many  clinical  settings  mostly  as  a bridge  to the  next
step.  In this  article,  we report  a case  of cardiogenic  shock  due  to acute  occlusion  of  left  main  coronary
artery  who  was  scheduled  to be  transferred  from  Iran  to  Germany  for the  next  treatment  (permanent
assist  device  implantation).  Impella  2.5 (Abiomed  Inc., Danvers,  MA,  USA),  a  short-term  assist  device,
made  the  long  distance  journey  possible.eywords:
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<Learning  objective:  Managing  of severe  cardiogenic  shock  by  early  revascularization  and  prompt
installation  of mechanical  circulatory  support  in peripheral  hospital  as  bridge  to  decision  and  successful
long-distance  transfer  on mechanical  circulatory  support.>
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A 54-year-old man, 187 cm and 92 kg, came to the emergency
oom with severe frequent resting chest pain and deteriorating
emodynamic status. The medical history was remarkable for an
ld myocardial infarction, a percutaneous angioplasty and stenting
n left anterior descending (LAD) artery 10 years prior to admis-
ion and a history of active heavy smoking. Electrocardiography
howed sinus tachycardia and ST-segment elevation in precordial
eads.
Transthoracic echocardiography revealed severe left ventricu-
ar systolic dysfunction, the left ventricular ejection fraction (LVEF)
as 5–10%. Left ventricular end-diastolic diameter was mildly
ncreased (62 mm)  and the interventricular septal and posterior
all thickness were likely preserved (10 and 8 mm,  respectively).
here was a left ventricular apical aneurysm. Left atrial area was
9 cm2 and right ventricular end-diastolic diameter was 34 mm.
here was a mild to moderate tricuspid regurgitation with Doppler
easured peak-systolic jet velocity of 3.8 m/s.
The patient lost consciousness while being examined in the
mergency room. On arrival the blood pressure could be measured
round 75 mmHg  but the pulses were rapidly lost to palpation along
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was promptly transferred to the catheterization unit and emergent
coronary angiography was  performed. His heart rate was  110 bpm
on arrival and 140 bpm on starting angiography. There was a patent
dominant right coronary artery (RCA) and a totally occluded left
main stem in distal portion (Figs. 1 and 2). We decided to perform
complete revascularization of left coronary system in catheteriza-
tion unit as a salvage strategy. Intra-aortic balloon pump (IABP) was
implanted due to severe hypotension and refractory ventricular
arrhythmia.
After wiring of LAD and left circumﬂex artery (LCX), balloon
angioplasty and stenting of distal left main artery, proximal LAD,
and LCX was performed with three bare-metal stents ensuring a
good angiographic result and thrombolysis in myocardial infarc-
tion (TIMI) grade 3 ﬂow in all coronary arteries (Fig. 3). Right
heart catheterization showed pulmonary arterial pressure (PAP)
of 55/35 mmHg  with a wedge pressure (PCWP) of 32 mmHg and
cardiac index (CI) of 1.9 l/min/m2.
Mechanical ventilation, IABP support and aggressive medical
therapy failed to stabilize the hemodynamic status over the follow-
ing 48 h. The patient was  again transferred to the catheterization
laboratory and upon conﬁrmation of patency of the coronary arter-
ies by selective angiography, we decided to implant the Impella
LP®2.5 (Abiomed Inc., Danvers, MA,  USA) for better hemody-
namic support (Fig. 4). PAP, PCWP, and CI were 60/35 mmHg,
llege of Cardiology.
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Fig. 1. Coronary angiography on arrival showed patent dominant right coronary
artery.
Fig. 2. Coronary angiography on arrival showed a totally occluded left main stem
in  the distal portion.
Fig. 3. Final primary angioplasty result showing thrombolysis in myocardial infarc-
tion grade 3 ﬂow in left coronary arteries.
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40 mmHg, and 1.6 l/min/m2 before implantation and improved to
45/25 mmHg, 28 mmHg, and 2.1 l/min/m2 after implantation.
Over the following days, the patient’s condition became dramat-
ically better with stabilization of blood pressure and disappearance
of arrhythmia; echocardiography revealed improvement in LVEF
(up to 20–25%) with a slight decrease in right ventricular end-
diastolic size (32 mm)  and a tricuspid regurgitation peak-systolic
velocity of 3.4 m/s; other measures remained the same.
The patient’s case was  discussed with the expert team at Berlin
Heart Institute and it was planned that he be transferred to Berlin
for the next therapeutic step. The ﬂight from Tehran to Berlin
on a Challenger 600 (Rega Swiss Ambulance) was accomplished
uneventfully with similar numbers and doses of inotropes. The
non-stop ﬂight was  performed at regular cruise speed at an alti-
tude of 10,000 m.  The pressure drop in the cabin (equivalent to
2000 m above sea level) was  well tolerated and required a slight
increase in the vasopressor dose. During the transport, the venti-
lated patient remained awake and informed about the situation,
mean blood pressure was maintained around 80 mmHg, heart rate
around 100 bpm and hematocrit around 30%, and the urine output
was over 75 cm3/h. Heparin infusion maintained activated par-
tial thromboplastin time between 50 and 60 s during ﬂight. After
arrival at the Berlin Heart Institute, he was admitted to an inten-
sive care unit on Impella support and heparin and was  scheduled
for implantation of a long-term left ventricular support device, but
unfortunately upon developing a massive intracranial hemorrhage
two days later, the patient died.
Discussion
Cardiogenic shock constitutes a complication of acute coronary
syndromes, occurring predominantly after an acute myocardial
infarction with ST elevation, and is associated with high mortality
rates, ranging from 56% to 74% in several reports [1–3]. Left ven-
tricular breakdown in patients with post-MI cardiogenic shock is
usually due to large areas of ischemia in consequence to extensive
coronary disease. Timely and reasonable revascularization policy
along with sufﬁcient hemodynamic support probably by ventricu-
lar assist devices may  lead to a better prognosis in these patients.
The IABP is the most widely used hemodynamic support
device. It works through counterpulsation, augmenting the dia-
stolic pressure and consequently the coronary perfusion pressure
and reducing the afterload, leading to an increase in cardiac out-
put. The most important limitations of IABP are the inability to
provide inadequate support in patients with severely compromised
LV function, as well as in patients with very rapid and irregular heart
rates. In the face of these limitations, new intravascular devices
have been developed, extending the concept of LV assistance from
linicalKey.com by Elsevier on May 14, 2019.
. Elsevier Inc. All rights reserved.
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support option for severe pulmonary artery hypertension complicated by car-144 H.R. Sanati et al. / Journal of Ca
he surgical arena to the catheterization laboratory, and thus allow-
ng the expansion of mechanical circulatory support indications.
hese devices have been evaluated in patients with hemodynamic
ollapse due to cardiogenic shock, acute myocarditis, transplant
ejection, or postcardiotomy [4,5].
The TandemHeart (CardiacAssist, Pittsburgh, PA, USA), a per-
utaneous assist device, has been used successfully for temporary
upport after cardiotomy and is said to be helpful to perform
omplex procedures (balloon aortic valvuloplasty and angioplasty)
n unstable patients. The main complication has been pericardial
leeding [10–12].
The Impella Recover LP 2.5 is a versatile and small device
hich can be easily implanted via percutaneous approach with-
ut any major complication (no need for septostomy as opposed
o TandemHeart). The Impella LP 2.5 is capable of pumping blood
p to 2.5 l/min [6–9]. In this case, possibly the ﬁrst human case
escription, the Impella was used as a short-term hemodynamic
upport tool for a patient in cardiogenic shock that enabled safe
ong-distance transport. Therefore, the Impella might be used as
 versatile, reliable, and safe support tool in a hub center organi-
ation in order to transfer eligible patients from small cardiologic
enters/departments to large centers with possibilities for trans-
lantation and long-term assist device implantation.
We assume the elevated blood pressure during waking up state
s well as over-anticoagulation to be plausible causes for our
atient’s hemorrhage. Lower anticoagulation levels with Impella
ight be reasonable and discussable, as has been addressed with
ther axial ﬂow assist devices [13]. Changes in cabin pressure dur-
ng ﬂight are less of a possibility to induce such a hemorrhage, even
nder intense anticoagulation.eferences
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